1. Canada Stocks

  2. •

    Healthcare

  3. •

    Medical - Devices
Therma Bright Inc.

Therma Bright Inc.

THRM.V
Therma Bright Inc.CA flagToronto Stock Exchange Ventures
0.05
CAD
+0.00
- -
3.06MMarket Cap
Therma Bright Inc.
THRM.V
(Toronto Stock Exchange Ventures)

Recent

price

0.05

P/E

ratio

- -

div

yld

- -

ROIC.AI

2009
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
0.02
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Revenue per Share
-0.22
-0.07
-0.09
0.1
0.01
-0.03
-0.01
-0.07
-0.07
-0.02
-0.03
-0.34
-0.21
-0.13
-0.06
-0.08
-0.07
Basic EPS, GAAP
-0.01
- -
- -
-0.01
-0.01
- -
- -
-0.01
-0.02
-0.01
-0.01
-0.13
-0.13
-0.08
-0.03
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
-1.85
-1.66
-0.93
-0.78
-0.69
-0.48
-0.4
-0.38
-0.3
-0.29
-0.26
-0.29
-0.39
-0.46
-0.33
-0.29
-0.27
Book Value per Share
-0.72
-0.7
-0.79
-0.65
-0.57
-0.13
-0.12
-0.06
-0.01
-0.02
0.01
0.04
0.09
-0.02
0.02
-0.03
-0.03
Tangible Book Value per Share
7
8
8
9
10
11
14
15
19
20
20
25
29
30
40
56
60
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Sales/Revenue/Turnover
-623.5
- -
- -
- -
- -
-20,514.16
-4,288.52
-3,097.72
-8,707.02
-5,833.76
-16,127.54
-221,317.56
-4,185.97
-15,391.92
-4,736.75
-2,202.58
-906.32
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
-2
-1
-1
1
- -
- -
- -
-1
-1
- -
-1
-9
-6
-4
-2
-4
-4
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
-876.33
- -
- -
- -
- -
-20,852.6
-4,298.37
-3,098.51
-8,769.54
-6,110.51
-16,565.74
-221,744.06
-4,218.03
-15,765.4
-9,402.79
-5,410.44
-2,951.53
Profit Margin (%)
-5
-6
-7
-6
-6
-1
-1
-1
- -
- -
- -
1
2
-2
-1
-2
-2
Working Capital
- -
- -
- -
- -
- -
1
1
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
LT Debt
-5
-6
-7
-6
-6
-1
-2
-1
- -
- -
- -
1
3
- -
1
-2
-2
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
-40.01
-30.04
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Oct'26
Jan'26
Apr'26
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
61
61
61
Market Capitalization
14
4
3

Working Capital

FRC

•

in mil. unless spec.
Oct'26
Jan'26
Apr'26
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
2
2
2
Payables & Accruals
- -
- -
2
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
313.55%
627.23%
-218.22%
Free Cash Flow
320.64%
549.48%
-85.48%
Net Income, GAAP
158.57%
249.71%
77.17%
Sales/Revenue/Turnover
420.71%
725.49%
207.9%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
-0.06
2025
- -
- -
- -
- -
-0.08
2026
- -
-0.01
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
OncoSil Medical Ltd (OSL.AX)
FUJIFILM Holdings Corporation (4901.T)
Brighter AB (publ) (BRIG.ST)
CYBERDYNE Inc. (7779.T)
Eiken Chemical Co., Ltd. (4549.T)
Erech Finance Cahalacha Ltd (EFNC.TA)
Business
Therma Bright Inc. (TSXV:THRM) develops, acquires, manufactures and markets proprietary healthcare and medical devices focused on respiratory diseases, vascular health and consumer medical devices for consumers and institutional markets worldwide. The company offers Venowave, a medical compression pump that treats poor circulation, prevents blood clots and alleviates post-thrombotic syndrome; InterceptCS, a cold sore prevention system using controlled topical heat and light to kill virally infected cells; Benepod, a hot and cold contrast therapy device for pain relief; TherOZap, a thermal therapy device that reduces inflammation, pain, itching from insect bites and stings; AcuVid, rapid antigen and antibody screening tests for COVID-19; Digital Cough Analyzer, an AI-powered app for detecting respiratory diseases including COVID-19 via cough analysis; and investments in InStatin's inhaled statin therapy for COVID-19 pneumonia and ARDS, plus Inretio's PREVA clot retriever for ischemic stroke treatment. Founded in 2010 and headquartered in Toronto, Canada, Therma Bright operates primarily in North America with expansion into U.S. markets. Recent developments include closing a $1 million CAD private placement in June 2024 to fund Digital Cough Analyzer and InStatin investments; expanding U.S. distribution partnership with Gen-X Med for Venowave in September 2025; securing an initial exclusive U.S. marketing contract with Global Wellness Products for consumer devices in March 2025; advancing FDA 513(g) submission for Digital Cough Analyzer as remote therapeutic monitoring; pursuing permanent HCPCS and CPT codes for Venowave; and completing a 1:8 share consolidation in July 2025.

Company News

APIChatGPT

  • feeds.newsfilecorp.com

    Therma Bright Inc. Investee Company, InStatin Expands its Inhaled Statin Programs to include COPD (Chronic Obstructive Pulmonary Disease) as its Lead Indication.